BRAX.CN - Braxia Scientific Corp.

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD

Braxia Scientific Corp.

700 Bay Street
Suite 1903
Toronto, ON M5G 1Z6

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Roger S. McIntyreChairman & CEO300kN/AN/A
Mr. Stephen R. BrooksChief Financial Officer180kN/AN/A
Mr. Peter RizakosChief Legal Officer & Gen. Counsel175kN/AN/A
Dr. Joshua RosenblatChief Medical & Scientific OfficerN/AN/AN/A
Mr. Jason WolkoveChief Information OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. Braxia Scientific Corp. is headquartered in Toronto, Ontario.

Corporate Governance

Braxia Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.